WO2008133847A1 - Procédé de fabrication d'un polysaccharide dialdéhyde ayant une pureté élevée - Google Patents
Procédé de fabrication d'un polysaccharide dialdéhyde ayant une pureté élevée Download PDFInfo
- Publication number
- WO2008133847A1 WO2008133847A1 PCT/US2008/005013 US2008005013W WO2008133847A1 WO 2008133847 A1 WO2008133847 A1 WO 2008133847A1 US 2008005013 W US2008005013 W US 2008005013W WO 2008133847 A1 WO2008133847 A1 WO 2008133847A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dialdehyde
- polysaccharide
- dextran
- polysaccharide dialdehyde
- salt
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 178
- 150000004676 glycans Chemical class 0.000 title claims abstract description 177
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 177
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 title claims abstract description 166
- 238000000034 method Methods 0.000 title claims abstract description 78
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims abstract description 40
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 27
- 239000011630 iodine Substances 0.000 claims abstract description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 45
- 229920002307 Dextran Polymers 0.000 claims description 43
- 229960002086 dextran Drugs 0.000 claims description 43
- 239000006228 supernatant Substances 0.000 claims description 39
- 239000012530 fluid Substances 0.000 claims description 38
- 239000003960 organic solvent Substances 0.000 claims description 38
- 239000002244 precipitate Substances 0.000 claims description 37
- 239000000706 filtrate Substances 0.000 claims description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 33
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 30
- 239000000047 product Substances 0.000 claims description 28
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 150000001768 cations Chemical class 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 17
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 238000002425 crystallisation Methods 0.000 claims description 14
- 230000008025 crystallization Effects 0.000 claims description 14
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 14
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 239000001110 calcium chloride Substances 0.000 claims description 8
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 8
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 8
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 8
- 230000001376 precipitating effect Effects 0.000 claims description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 claims description 6
- ICIWUVCWSCSTAQ-UHFFFAOYSA-N iodic acid Chemical class OI(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-N 0.000 claims description 6
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 4
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 4
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 4
- 239000001639 calcium acetate Substances 0.000 claims description 4
- 229960005147 calcium acetate Drugs 0.000 claims description 4
- 235000011092 calcium acetate Nutrition 0.000 claims description 4
- 229910001622 calcium bromide Inorganic materials 0.000 claims description 4
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 claims description 4
- 229940076286 cupric acetate Drugs 0.000 claims description 4
- 229960003280 cupric chloride Drugs 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 229940071125 manganese acetate Drugs 0.000 claims description 4
- 239000011565 manganese chloride Substances 0.000 claims description 4
- 235000002867 manganese chloride Nutrition 0.000 claims description 4
- 229940099607 manganese chloride Drugs 0.000 claims description 4
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000004246 zinc acetate Substances 0.000 claims description 4
- 239000011592 zinc chloride Substances 0.000 claims description 4
- 235000005074 zinc chloride Nutrition 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 3
- XZXYQEHISUMZAT-UHFFFAOYSA-N 2-[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound CC1=CC=C(O)C(CC=2C(=CC=C(C)C=2)O)=C1 XZXYQEHISUMZAT-UHFFFAOYSA-N 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002488 Hemicellulose Polymers 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229940107816 ammonium iodide Drugs 0.000 claims description 3
- ITHZDDVSAWDQPZ-UHFFFAOYSA-L barium acetate Chemical compound [Ba+2].CC([O-])=O.CC([O-])=O ITHZDDVSAWDQPZ-UHFFFAOYSA-L 0.000 claims description 3
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims description 3
- 229910001626 barium chloride Inorganic materials 0.000 claims description 3
- LHQLJMJLROMYRN-UHFFFAOYSA-L cadmium acetate Chemical compound [Cd+2].CC([O-])=O.CC([O-])=O LHQLJMJLROMYRN-UHFFFAOYSA-L 0.000 claims description 3
- 229940046413 calcium iodide Drugs 0.000 claims description 3
- 229910001640 calcium iodide Inorganic materials 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 229960000633 dextran sulfate Drugs 0.000 claims description 3
- 229920001249 ethyl cellulose Polymers 0.000 claims description 3
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 3
- 229960004667 ethyl cellulose Drugs 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- -1 lead acetate Chemical compound 0.000 claims description 3
- 229940046892 lead acetate Drugs 0.000 claims description 3
- HWSZZLVAJGOAAY-UHFFFAOYSA-L lead(II) chloride Chemical compound Cl[Pb]Cl HWSZZLVAJGOAAY-UHFFFAOYSA-L 0.000 claims description 3
- 229960002523 mercuric chloride Drugs 0.000 claims description 3
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 claims description 3
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 229960002900 methylcellulose Drugs 0.000 claims description 3
- 238000003801 milling Methods 0.000 claims description 3
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- 235000009518 sodium iodide Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 229910001631 strontium chloride Inorganic materials 0.000 claims description 3
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 claims description 3
- RXSHXLOMRZJCLB-UHFFFAOYSA-L strontium;diacetate Chemical compound [Sr+2].CC([O-])=O.CC([O-])=O RXSHXLOMRZJCLB-UHFFFAOYSA-L 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 15
- 239000000853 adhesive Substances 0.000 abstract description 12
- 230000001070 adhesive effect Effects 0.000 abstract description 12
- 239000000017 hydrogel Substances 0.000 abstract description 11
- 230000003647 oxidation Effects 0.000 abstract description 9
- 238000001556 precipitation Methods 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 241000894007 species Species 0.000 description 13
- 239000007787 solid Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 239000003106 tissue adhesive Substances 0.000 description 4
- 238000004846 x-ray emission Methods 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 229940075469 tissue adhesives Drugs 0.000 description 3
- 239000004151 Calcium iodate Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003872 anastomosis Effects 0.000 description 2
- 230000000181 anti-adherent effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- UHWJJLGTKIWIJO-UHFFFAOYSA-L calcium iodate Chemical compound [Ca+2].[O-]I(=O)=O.[O-]I(=O)=O UHWJJLGTKIWIJO-UHFFFAOYSA-L 0.000 description 2
- 235000019390 calcium iodate Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000003886 intestinal anastomosis Effects 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940059251 calcium bromide Drugs 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000000743 hydrocarbylene group Chemical group 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Definitions
- the problem to be solved is to provide a method for making polysaccharide dialdehydes that provides a product that has a low level of iodine-containing species and is simple and rapid.
- R is a hydrocarbylene group having 2 to 5 carbon atoms.
- the purified polysaccharide dialdehyde may be dried using any suitable method, for example, using heat, vacuum, a combination of heat and vacuum, or flowing a stream of dry air or a dry inert gas such as nitrogen over the purified polysaccharide dialdehyde.
- the purified polysaccharide dialdehyde is dried in a vacuum oven at 20 °C for about 16 to 24 hours.
- the reactor contents were transferred to a beaker and the beaker was chilled in an ice/acetone bath until a precipitate comprising a periodate salt was formed.
- the mixture was then transferred back to the reactor and stirred for 30 min at 2 0 C.
- the reactor contents were filtered, yielding 17.13 g of solids.
- the filtrate was transferred to a beaker and 18.75 g of CaCI 2 .2H 2 O was added to the filtrate.
- the mixture was stirred for 30 min at room temperature forming a precipitate comprising calcium iodate.
- the precipitate was filtered, yielding 21.45 g of solids.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
L'invention porte sur un procédé de fabrication de polysaccharide dialdéhydes, qui utilise une combinaison d'étapes de précipitation et de séparation pour purifier le polysaccharide dialdéhyde formé par oxydation d'un polysaccharide par un periodate. Le procédé est simple, rapide et fournit un polysaccharide dialdéhyde ayant de très faibles taux d'espèces à teneur en iode. Le polysaccharide dialdéhyde est particulièrement approprié pour préparer des adhésifs en hydrogel pour des applications médicales.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08743049A EP2137219A1 (fr) | 2007-04-24 | 2008-04-18 | Procédé de fabrication d'un polysaccharide dialdéhyde ayant une pureté élevée |
| JP2010506221A JP2010525140A (ja) | 2007-04-24 | 2008-04-18 | 高純度を有する多糖ジアルデヒドを製造する方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92594807P | 2007-04-24 | 2007-04-24 | |
| US60/925,948 | 2007-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008133847A1 true WO2008133847A1 (fr) | 2008-11-06 |
Family
ID=39615615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2008/005013 WO2008133847A1 (fr) | 2007-04-24 | 2008-04-18 | Procédé de fabrication d'un polysaccharide dialdéhyde ayant une pureté élevée |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2137219A1 (fr) |
| JP (1) | JP2010525140A (fr) |
| CN (1) | CN101663328A (fr) |
| WO (1) | WO2008133847A1 (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010059279A2 (fr) | 2008-11-19 | 2010-05-27 | E. I. Du Pont De Nemours And Company | Adhésif de type hydrogel pour tissus formés à partir de polysaccharide aminé et de polyéther à plusieurs bras fonctionnalisé par aldéhyde |
| WO2010111594A1 (fr) | 2009-03-27 | 2010-09-30 | E. I. Du Pont De Nemours And Company | Adhésif et agent de scellement tissulaire comprenant un polymère de polyglycérol et d'aldéhyde |
| WO2011002956A1 (fr) | 2009-07-02 | 2011-01-06 | E. I. Du Pont De Nemours And Company | Polysaccharides fonctionnalisés par aldéhyde |
| WO2011002888A2 (fr) | 2009-07-02 | 2011-01-06 | E. I. Du Pont De Nemours And Company | Adhesif de type hydrogel pour tissu a usage medical |
| US20120009132A1 (en) * | 2008-12-15 | 2012-01-12 | Council Of Scientific & Industrial Research | Transparent Xyloglucan/Chitosan Gel and a Process for the Preparation Thereof |
| WO2012012359A1 (fr) * | 2010-07-19 | 2012-01-26 | Actamax Surgical Materials, Llc | Procédé de préparation d'un dialdéhyde polysaccharidique de pureté élevée |
| WO2013030264A1 (fr) | 2011-08-31 | 2013-03-07 | Ecosynth Bvba | Procédé pour modifier des glucides |
| WO2024033633A1 (fr) * | 2022-08-08 | 2024-02-15 | Innospec Limited | Composition comprenant un polysaccharide oxydé |
| CN118697011A (zh) * | 2024-06-04 | 2024-09-27 | 广东中耀环境科技有限公司 | 一种高分散碱式氯化铜及其制备方法 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103030701B (zh) * | 2012-12-05 | 2015-07-08 | 深圳先进技术研究院 | 改性淀粉交联剂的制备方法 |
| CN103709267A (zh) * | 2013-11-28 | 2014-04-09 | 江南大学 | 一种双醛羧甲基壳聚糖的制备方法 |
| US10787524B2 (en) * | 2015-04-03 | 2020-09-29 | Dupont Industrial Biosciences Usa, Llc | Oxidized dextran |
| JP6811956B2 (ja) * | 2016-09-06 | 2021-01-13 | 国立大学法人北陸先端科学技術大学院大学 | 分解制御性ハイドロゲル |
| CN106835367B (zh) * | 2017-02-23 | 2019-04-16 | 东北师范大学 | 一种交联多糖纤维及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997041899A1 (fr) * | 1996-05-03 | 1997-11-13 | Innogenetics N.V. | Nouveaux medicaments contenant de la gelatine reticulee avec des polysaccharides oxydes |
| WO2000075070A1 (fr) * | 1999-06-07 | 2000-12-14 | Sca Hygiene Products Zeist B.V. | Procede de regeneration d'acide periodique |
| US20050002893A1 (en) | 2001-10-24 | 2005-01-06 | Helmut Goldmann | Composition consisting of a polymer containing amino groups and an aldehyde containing at least three aldehyde groups |
| US20060078536A1 (en) | 2004-10-07 | 2006-04-13 | Kodokian George K | Polysaccharide-based polymer tissue adhesive for medical use |
-
2008
- 2008-04-18 WO PCT/US2008/005013 patent/WO2008133847A1/fr active Application Filing
- 2008-04-18 EP EP08743049A patent/EP2137219A1/fr not_active Withdrawn
- 2008-04-18 JP JP2010506221A patent/JP2010525140A/ja active Pending
- 2008-04-18 CN CN200880013032A patent/CN101663328A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997041899A1 (fr) * | 1996-05-03 | 1997-11-13 | Innogenetics N.V. | Nouveaux medicaments contenant de la gelatine reticulee avec des polysaccharides oxydes |
| WO2000075070A1 (fr) * | 1999-06-07 | 2000-12-14 | Sca Hygiene Products Zeist B.V. | Procede de regeneration d'acide periodique |
| US20050002893A1 (en) | 2001-10-24 | 2005-01-06 | Helmut Goldmann | Composition consisting of a polymer containing amino groups and an aldehyde containing at least three aldehyde groups |
| US20060078536A1 (en) | 2004-10-07 | 2006-04-13 | Kodokian George K | Polysaccharide-based polymer tissue adhesive for medical use |
Non-Patent Citations (4)
| Title |
|---|
| HALSALL ET AL., J. CHEM. SOC., 1947, pages 1427 - 1432 |
| MO ET AL., J. BIOMATER. SCI. POLYMER EDN., vol. 11, 2000, pages 341 - 351 |
| SEITZ ET AL., JOURNAL FOR PRAKTISHE CHEMIE (LEIPZIG), vol. 311, no. 1, 1969, pages 141 - 146 |
| URAZ ET AL., CARBOHYDRATE POLYMERS, vol. 34, 1997, pages 127 - 130 |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010059279A2 (fr) | 2008-11-19 | 2010-05-27 | E. I. Du Pont De Nemours And Company | Adhésif de type hydrogel pour tissus formés à partir de polysaccharide aminé et de polyéther à plusieurs bras fonctionnalisé par aldéhyde |
| US20120009132A1 (en) * | 2008-12-15 | 2012-01-12 | Council Of Scientific & Industrial Research | Transparent Xyloglucan/Chitosan Gel and a Process for the Preparation Thereof |
| US8623336B2 (en) * | 2008-12-15 | 2014-01-07 | Council Of Scientific & Industrial Research | Transparent xyloglucan/chitosan gel and a process for the preparation thereof |
| WO2010111594A1 (fr) | 2009-03-27 | 2010-09-30 | E. I. Du Pont De Nemours And Company | Adhésif et agent de scellement tissulaire comprenant un polymère de polyglycérol et d'aldéhyde |
| WO2011002956A1 (fr) | 2009-07-02 | 2011-01-06 | E. I. Du Pont De Nemours And Company | Polysaccharides fonctionnalisés par aldéhyde |
| WO2011002888A2 (fr) | 2009-07-02 | 2011-01-06 | E. I. Du Pont De Nemours And Company | Adhesif de type hydrogel pour tissu a usage medical |
| WO2012012359A1 (fr) * | 2010-07-19 | 2012-01-26 | Actamax Surgical Materials, Llc | Procédé de préparation d'un dialdéhyde polysaccharidique de pureté élevée |
| WO2013030264A1 (fr) | 2011-08-31 | 2013-03-07 | Ecosynth Bvba | Procédé pour modifier des glucides |
| WO2024033633A1 (fr) * | 2022-08-08 | 2024-02-15 | Innospec Limited | Composition comprenant un polysaccharide oxydé |
| CN118697011A (zh) * | 2024-06-04 | 2024-09-27 | 广东中耀环境科技有限公司 | 一种高分散碱式氯化铜及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2137219A1 (fr) | 2009-12-30 |
| CN101663328A (zh) | 2010-03-03 |
| JP2010525140A (ja) | 2010-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008133847A1 (fr) | Procédé de fabrication d'un polysaccharide dialdéhyde ayant une pureté élevée | |
| US4278790A (en) | Novel cellulose solutions | |
| CN103724455B (zh) | 一种透明质酸衍生物及其水凝胶的制备方法 | |
| WO2008071058A1 (fr) | Dérivé macromoléculaire modifié par un groupe mercapto et matériau réticulé | |
| EP1419792A1 (fr) | Complexe polycation-glycosaminoglycane reticule par un agent de reticulation polyfonctionnel et procede de production associe | |
| WO2012012359A1 (fr) | Procédé de préparation d'un dialdéhyde polysaccharidique de pureté élevée | |
| US20120094955A1 (en) | Method of dissolving an oxidized polysaccharide in an aqueous solution | |
| EP0212145B1 (fr) | Sels d'ammonium quaternaires de polysaccharides naturels ayant une activité hypocholestérolémique | |
| WO2010118285A1 (fr) | Procédé de dissolution d'un polysaccharide oxydé dans une solution aqueuse | |
| CN104710653A (zh) | 一种壳聚糖水凝胶及其制备方法与应用 | |
| CN112812201B (zh) | 巯基改性透明质酸及其制备方法和用途 | |
| CN115466411A (zh) | 一种双硫键交联透明质酸水凝胶的制备方法 | |
| US20030055211A1 (en) | Chitosan condensation products, their preparation and their uses | |
| AU658986B2 (en) | N-substituted chitosan derivatives, process for their preparation and the use thereof | |
| CN100494223C (zh) | 季胺盐改性的壳聚糖亲核no供体的合成方法 | |
| JP2015143311A (ja) | シクロデキストリングラフトキトサンの製造法 | |
| CN101003632A (zh) | 制备壳聚糖-接枝-聚乳酸的方法 | |
| DE2813921C2 (de) | Verfahren zur Herstellung von ionischen Pullulangelen sowie deren Verwendung als Molekularsiebe zur Trennung und Reinigung | |
| CN1205229C (zh) | 羟丙基纤维素的制备方法 | |
| CN110343263A (zh) | 一种基于氢氧化钾和低温溶解壳聚糖的方法 | |
| CN114835826B (zh) | 一种两性离子纤维素及其制备方法与应用 | |
| JPH0455609B2 (fr) | ||
| US20130303748A1 (en) | Method for making aldehyde-functionalized polysaccharides | |
| Sabaa | Chitosan-g-copolymers: synthesis, properties, and applications | |
| KR20170122657A (ko) | 의료고무 배합용 유기 가황제 및 이의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 200880013032.8 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08743049 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2008743049 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010506221 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |